Abstract | BACKGROUND: METHODS: We included 620 consecutive patients undergoing TCPC between 1994 and 2021. Prevalence and predictors for onset of PLE/PB were evaluated. Death and heart transplantation after onset of PLE/PB were examined. RESULTS: A total of 41 patients presented with PLE/PB (31 with PLE, 15 with PB, and 5 developed both PLE and PB). Their median age at TCPC was 2.2 (interquartile ranges [IQRs], 1.7-3.7) years, and time period to onset for PLE was 2.6 (IQR: 1.0-6.6) years and for PB was 1.1 (IQR: 0.3-4.1) years after TCPC. Independent factors for developing PLE/PB were dominant right ventricle (RV, hazard ratio [HR], 2.243; 95% confidence interval [CI], 1.129-4.458, P = .021) and prolonged pleural effusion after TCPC (HR, 2.101; 95% CI, 1.090-4.049, P = .027). In PLE/PB population, freedom from death or transplantation after PLE/PB diagnosis at 5 and 10 years were 88.7% and 76.4%, respectively. Eleven surgical interventions were performed in 10 patients, comprising atrioventricular valve repairs (n = 4), Fontan pathway revisions (n = 2), pacemaker implantation (n = 2), secondary fenestration (n = 1), diaphragm plication (n = 1), and ventricular assist device implantation (n = 1). In nine patients, a recovery from PLE with the resolution of PLE symptoms and normal protein levels was achieved. Eight patients died and the remaining continued to have challenging protein loss. CONCLUSIONS:
|
Authors | Veronika Hammer, Thibault Schaeffer, Helena Staehler, Paul Philipp Heinisch, Melchior Burri, Nicole Piber, Julia Lemmer, Alfred Hager, Peter Ewert, Jürgen Hörer, Masamichi Ono |
Journal | World journal for pediatric & congenital heart surgery
(World J Pediatr Congenit Heart Surg)
Vol. 14
Issue 6
Pg. 691-698
(Nov 2023)
ISSN: 2150-136X [Electronic] United States |
PMID | 37551120
(Publication Type: Journal Article)
|
Topics |
- Humans
- Fontan Procedure
(adverse effects)
- Protein-Losing Enteropathies
(complications)
- Retrospective Studies
- Pulmonary Artery
(surgery)
- Bronchitis
(etiology)
- Heart Defects, Congenital
(surgery)
- Treatment Outcome
|